QA: Paratek Pharmaceuticals Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2022_Paratek_Pharmaceuticals_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 152,100,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 794,000
3 remainder_Assets 30,146,000
4 LiabilitiesCurrent 31,297,000
5 LiabilitiesNoncurrent 258,513,000
6 remainder_Liabilities 21,846,000
7 CostOfGoodsAndServicesSold 85,927,201
8 SellingGeneralAndAdministrativeExpense 151,950,220
9 ResearchAndDevelopmentExpense 32,079,871
10 remainder_Expenses 15,464,799
11 remainder_Revenues 545,517,132
12 remainder_NetIncome -128,851
13 remainder_ComprehensiveNetIncome -28,016
  yvar yval
0 Assets 183,869,000
1 Liabilities 311,656,000
2 Expenses 285,422,091
3 Revenues 545,517,132
4 StockholdersEquity -127,787,000
5 NetIncome 259,966,190
6 ComprehensiveNetIncome 259,952,182
7 BaseVar 663,310,545
8 EconomicCapitalRatiobeforeLimitedLiability -0.0752
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time